[1]
R. M. HamaSalih, T. A. Aziz, and K. S. Hamaamin, “Semaglutide Mitigates Doxorubicin-Induced Hepatic and Renal Damage: Functional, Anti-Inflammatory, and Histopathological Insights”, Al-Rafidain J Med Sci, vol. 10, no. 1, pp. 163–169, Feb. 2026.